Nymox Pharmaceutical Corporation (NYMXF)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Aug 18, 2026, 4:00 PM EST
Nymox Pharmaceutical Market Cap
Nymox Pharmaceutical has a market cap or net worth of $21.01 thousand as of August 19, 2026. Its market cap has decreased by -99.60% in one year.
Market Cap
21.01K
Enterprise Value
3.23M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since November 26, 1997, Nymox Pharmaceutical's market cap has decreased from 118.04M to 21.01K, a decrease of -99.98%. That is a compound annual growth rate of -25.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 21.01K | -99.49% |
| Dec 31, 2025 | 4.10M | -56.61% |
| Dec 31, 2024 | 9.45M | -82.82% |
| Dec 29, 2023 | 55.03M | 86.49% |
| Dec 30, 2022 | 29.51M | -73.23% |
| Dec 31, 2021 | 110.23M | -42.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Spencer Pharmaceutical | 27.13K |
| Health Sciences Group | 20.51K |
| Regenicin | 15.35K |
| Statera Biopharma | 14.52K |
| IO Biotech | 14.39K |
| NanoLogix | 13.03K |
| Vaxxinity | 12.68K |
| ObsEva | 11.72K |